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Abstract
Background: The purpose of this study was a retrospective analysis of outcomes following laparoscopic adrenalectomy (LA) performed 
for benign adrenal tumours responsible for various endocrinological disorders. The patients were diagnosed with non-functioning (NFT) 
and functioning adrenal tumours (FT) including pheochromocytoma (PH), Conn’s syndrome (CO) and Cushing’s (CS) syndrome.
Material and methods: A total of 165 LAs were carried out between August 1995 and September 2009 via either the transperitoneal (n = 38) 
or retroperitoneal (n = 127) approach. The analysed factors included demographic data of patients, the American Association of Anaes-
thesiology score (ASA), indication for surgery, tumour size and side, intraoperative and postoperative outcome of LA including duration 
of surgery, blood loss, time until ambulation, length of hospital stay, time until return to normal activity, the complication rate, as well as 
the conversion rate to open adrenalectomy.
Results: There were 111 patients with NFT and 54 with FT. Patients with NFT were significantly older than those with CO (p < 0.05). 
The mean size of the lesion differed between CO and other adrenal tumours (p < 0.05) as well as between NFT and PH (p < 0.05). All 
the lesions except aldosteronomas were detected predominantly in the right adrenal gland (p < 0.05). However, despite the different 
characteristic and clinical disorders related to laparoscopically removed adrenal tumours, the intraoperative and postoperative outcomes 
did not significantly differ in most cases between the analysed groups of patients. 
Conclusion: This study shows that LA is a safe, effective, and well-tolerated procedure despite the hormonal activity of the removed le-
sions. Minimal invasive surgery may be recommended as the ‘gold standard’ in the treatment of both functioning and non-functioning 
benign tumours of the adrenal gland. (Pol J Endocrinol 2011; 62 (6): 512–516)
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Streszczenie
Wstęp: Celem tego badania była retrospektywna analiza wyników adrenalektomii laparoskopowej (LA) wykonywanej z powodu 
łagodnych guzów nadnerczy mogących powodować różne zaburzenia endokrynologiczne. U pacjentów rozpoznawano nieczynne 
hormonalnie guzy nadnerczy (NFT) oraz hormonalnie czynne guzy nadnerczy (FT), w tym guz chromochłonny (PH), zespół Conna 
(CO) i zespół Cushinga (CS).
Material i metody: Pomiędzy sierpniem 1995 r. a wrześniem 2009 r. wykonano łącznie 165 LA z dostępu przezotrzewnowego (n = 38) lub 
zaotrzewnowego (n = 127). Analizowanymi czynnikami były: dane demograficzne pacjentów, wynik skali ASA, wskazanie do operacji, 
rozmiar guza i jego umiejscowienie, śródoperacyjne i pooperacyjne wyniki LA w tym czas trwania operacji, utratę krwi, czas uruchomienia 
chorych, długość hospitalizacji, czas powrotu do normalnej aktywności, śródoperacyjne i pooperacyjne powikłania, jak również wskaźnik 
konwersji do otwartej adrenalektomii.
Wyniki: Badaniem objęto 111 pacjentów z NFT i 54 z FT. Pacjenci z NFT byli istotnie starsi niż pacjenci z CO (p < 0,05). Średnia wielkość 
zmiany różniła się pomiędzy CO i innymi guzami nadnerczy (p < 0,05), jak również pomiędzy NFT i PH (p < 0,05). Wszystkie zmiany za 
wyjątkiem aldosteronoma wykrywano głównie w prawym nadnerczu (p < 0,05). Mimo różnych cech charakterystycznych oraz zaburzeń 
klinicznych związanych z usuwanymi laparoskopowo guzami nadnerczy w większości przypadków nie było istotnych różnic wyników 
środoperacyjnych i pooperacyjnych pomiędzy analizowanymi grupami pacjentów. 
Wnioski: Przedstawione badanie pokazuje, że LA jest bezpiecznym, efektywnym i dobrze tolerowanym przez chorych zabiegiem mimo 
czynności hormonalnej usuwanych zmian ogniskowych. Małoinwazyjny zabieg operacyjny można uznać za metodę referencyjną w chi-
rurgii zarówno czynnych, jak i nieczynnych hormonalnie łagodnych guzów nadnerczy. (Endokrynol Pol 2011; 62 (6): 512–516)
Słowa kluczowe: adrenalektomia laparoskopowa, hormonalnie czynne guzy nadnerczy, hormonalnie nieczynne guzy nadnerczy
Jerzy Lubikowski, Department of Surgery, Samodzielny Publiczny Wojewodzki Szpital Zespolony, ul. Arkonska 4, 71–455 Szczecin, Poland, 
fax: +48 91 425 35 42, e-mail: jerzy@lubikowski.pl
513
Endokrynologia Polska/Polish Journal of Endocrinology 2011; 62 (6)
PR
A
C
E 
O
R
Y
G
IN
A
LN
E
Introduction
The first laparoscopic adrenalectomies described in 
the literature were carried out in 1992 [1, 2]. This mini-
mally invasive procedure is now considered the “gold 
standard” for the removal of benign functioning and 
non-functioning adrenal tumours [3–6]. However, it has 
not been demonstrated unequivocally in the literature 
whether the hormonal activity of the operated adrenal 
tumours has any influence on the outcome of LA [7–10]. 
There are two main laparoscopic approaches used 
for adrenalectomy. Transperitoneal laparoscopic adrena-
lectomy (TLA) appears to be the procedure of choice 
for pheochromocytoma, bilateral adrenal tumours as 
well as lesions that are larger than 6 cm in diameter [6, 
9, 11, 12]. Retroperitoneal laparoscopic adrenalectomy 
(RLA) is advocated primarily for small functioning and 
non-functioning adrenal adenomas [13–16]. 
NFT is considered an indication for surgery if its 
diameter exceeds 4 cm, while FT is removed regardless 
of the tumour size [4, 17]. The technical restrictions, 
however, limit the indications for LA for tumours that 
are bigger than 12 cm in diameter. Moreover, malignant 
adrenal tumours, both primary and metastatic, are 
still considered a controversial indication for minimal 
invasive surgery [3, 4].
This study was designed primarily to analyse the 
perioperative results of endoscopic removal of different 
adrenal tumours in respect of their hormonal secretion. 
We also aimed to find out if there is an influence of other 
factors, such as size and side of adrenal tumour, and the 
patient’s age, on the outcome of LA. 
Material and methods
A retrospective analysis of the computer database for 
LAs performed at the Department of General and Trans-
plant Surgery, M. Curie Hospital in Szczecin, Poland 
was done. Between August 1995 and September 2009, 
there were 165 LAs performed via either transperitoneal 
(n = 38) or retroperitoneal (n = 127) approaches. The 
analysed group included 122 women and 43 men, 
mean age of 52 (range: 18–79) years. All patients had 
preoperative endocrine evaluation. Their health status 
was classified according to the American Association of 
Anaesthesiology score. The indications for surgery were 
both benign and non-functioning (size > 4 cm or smaller 
if co-existing with severe blood hypertension) as well as 
functioning adrenal tumours. Benign bilateral as well 
as metastatic and primary malignant adrenal lesions 
removed using LA were excluded from the analysis. The 
indication for surgery, the patient’s age, the tumour side 
and size, duration of surgery, blood loss, perioperative 
morbidity, conversion rate to OA, time until ambula-
tion, length of hospital stay and time until return to 
normal activity were all evaluated. The hospital stay 
was calculated from the day of surgery. Patients were 
questioned regarding their return to normal activity 
during the check-up visit in the outpatient department 
or via a telephone questionnaire. Return to normal acti-
vity included resumption of full-time working, as well 
as home, social or sport activities.
Transperitoneal laparoscopic adrenalectomy was 
performed according to the method described by 
Gagner [2] while extraperitoneal laparoscopic adrena-
lectomy followed the approach of Whittle [18] and 
Kelly [19].
The data was analysed employing Kruskal-Wallis 
test, Mann-Whitney test, c2 and Fisher exact test from 
the computer programs (Statistica 7.1). Differences were 
considered statistically significant when p < 0.05.
Results
The most frequent indication for LA (Table I) was NFT 
(67%). The actual physical status of the patients (ASA 
score) undergoing LA was not significantly (NS) related 
to the type of endocrinological disorders accompanying 
the removed adrenal tumour.
The significant difference regarding the mean age 
of patients with adrenal tumours was observed only 
between those with NFT and CO (p = 0.008) (Table I). 
The female to male ratio was similar in all analysed 
groups of patients (NS).
 The mean size of the adrenal lesion (Table I) dif-
fered significantly between patients who were treated 
Table I. Demographic and tumour characteristics
Tabela I. Dane demograficzne i cechy guzów
Tumour type n (%) Mean age (years ± SD) Mean size (cm ± SD) Side — R/L n (%)
NFT 111 (67.3) 56.7 ± 11.5 3.8 ± 1.2 73/38 (66/34)
CO 25 (15.1) 49.9 ± 8.8 2.5 ± 0.8 6/19 (24/76) 
CS 19 (11.5) 52.1 ±13.0 3.8 ± 1.3 11/8 (58/42)
PH 10 (6.1) 53.3 ± 12.1 4.6 ± 0.9 8/2 (80/20)
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for CO and other tumours including PH (p = 0.00002), 
CS (p = 0.001) and NFT (p = 0.000001), and it was also 
different for NFT vs. PH (p = 0.009).
The majority of adrenal tumours were diagnosed 
in the right adrenal gland, with the exception of CO 
(p = 0.001). 
The mean operative time and blood loss did not 
significantly depend on the type of removed adrenal 
lesion (Table II). 
There was a significant difference concerning time 
until ambulation after the operations performed for CS 
vs. NFT (p = 0.04) and vs. PH (p = 0.02) (Table III). How-
ever, the length of hospital stay, as well as the mean time 
until return to normal activity, were all similar between 
the analysed groups of patients (NS). The incidence of 
conversions to OA, as well as the intraoperative and 
postoperative complication rate, did not differ signifi-
cantly between the groups (Table IV).
Discussion
Over the last two decades, LA has become the surgical 
procedure of choice in the treatment of most benign 
adrenal lesions. This approach is suitable for removal of 
both FT and NFT [9]. The outcome of these procedures 
does not appear to depend generally on the manner of 
hormonal secretion by the adrenal lesion. The tumours 
responsible for CS and CO, PH and incidentaloma can 
be successfully operated on laparoscopically despite 
their different adrenal origins and varying clinical 
symptoms [3–5, 10]. Benign NFT, however, should be 
removed only when its size exceeds 4 cm in diameter 
[17]. If the NFT is smaller, it is considered an indication 
for surgery in patients with co-existing and severe blood 
hypertension [20]. The large size of an adrenal tumour 
(> 8 cm) and/or the evidence of its local invasiveness 
(both primary and metastatic adrenal malignancy) are 
still considered in many centres to be contraindications 
to a laparoscopic approach [3, 4, 10, 12, 21–23].
The differences in adrenal surgery and its outcome 
might depend not only on the tumour secretion but 
also its size and side as well as the age of the patient. 
These individual features of the adrenal tumour could 
potentially influence the outcome of the laparoscopic 
procedure [6, 10]. Moreover, different adrenal lesions 
can be removed employing any endoscopic approach. 
Ideally however, the surgical access is matched to the 
type of adrenal tumour. We believe that in the case of 
adenomas, the small adrenal lesions can be operated 
on using lateral or posterior extraperitoneal procedure 
despite their hormonal activity, while larger ones should 
be removed by the transperitoneal approach. In the 
case of surgery for chromaffin tumours, the transperi-
toneal access is usually required because of the need 
for an early closure of the adrenal vein. It allows the 
early occlusion of the vein, avoiding the life-threatening 
output of catecholamines [6, 9].
NFT occurs more frequently in elderly patients. It is 
usually discovered incidentally with ultrasound, CT or 
MR examinations performed for other indications [4]. 
The functioning adenomas and pheochromocytomas 
are detected usually because of specific symptoms ac-
companying the growth of the tumour. They are found 
more frequently one or two decades earlier than inci-
dentalomas, as was also shown in this study. 
Because of the limitations of minimal invasive 
surgery, the size of the adrenal tumour could have 
an influence on the performance of the procedure [6]. 
Table II. Intraoperative outcome of LA. Mean values
Tabela II. Śródoperacyjne wyniki LA. Wartości średnie
Tumour type Duration of LA 
(min ± SD)
Blood loss 
(ml ± SD)
NFT (n = 111) 137.8 ± 50.4 152.1 ± 185.3
CO (n = 25) 133.4 ± 42.2 145.6 ± 154.4
CS (n = 19) 144.4 ± 57.1 173.1 ± 238.1
PH (n = 10) 164.5 ± 62.2 149.0 ± 109.6
Table III. Postoperative outcome of LA. Values presented as 
means
Tabela III. Pooperacyjne wyniki LA. Wartości średnie
Tumour type Time until 
ambulation 
(hours ± SD)
Hospital stay 
(days ± SD)
Return to 
normal activity 
(days ± SD)
NFT (n =111) 19.3 ± 9.5 5.2 ± 3.5 15.3 ± 9.6
CO (n = 25) 17.6 ± 8.7 4.6 ± 2.4 13.5 ± 6.7
CS (n = 19) 16.2 ± 9.5 4.4 ± 1.5 17.8 ± 12.8
PH (n = 10) 20.8 ± 5.2 6.9 ± 3.6 18.0 ± 7.0
Table IV. Rate of conversion to OA. The intraoperative 
complication (IC) rate and the postoperative complication 
(PC) rate
Tabela IV. Wskaźnik konwersji do OA. Wskaźniki powikłań 
śródoperacyjnych (IC) i pooperacyjnych (PC)
Tumour type Conversion 
rate
IC rate PC rate
NFT (n = 111) 20 (18.02%) 18 (16.3%) 12 (10.8%)
CO (n = 25) 3 (12.0%) 5 (20.0%) 4 (16.6%)
CS (n = 19) 3 (15.79%) 6 (31.5%) 2 (11.1%)
PH (n = 10) 0 (0%) 2 (20.0%) 2 (20.0%)
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Many authors have shown that the mean size of the 
lesion was largest in patients with PH [4, 6, 10]. The 
mean size of PH was also largest in our series, with the 
smallest diameter belonging to aldosteronomas. The 
technique of the procedure for right and left adrenal 
tumours differs because of the varying anatomy on 
both sides of the body, but it should not have any im-
portant influence on the outcome of surgery [6]. In our 
analysis, most of the tumours were located on the right 
side, while aldosteronomas were detected mostly on 
the left side. Despite the significant difference between 
the tumour size in a case of CO and other lesions, as 
well as the predominant left location of CO, we did not 
observe a significant influence of these factors on the 
outcome of LA.
In our study, the type of the hormonal secretion of 
the removed adrenal tumour, its size and side did not 
have any significant influence on the mean duration of 
LA or the average blood loss. The review by Gumbs and 
Gagner of 19 papers with the largest published series 
of more than 100 LAs, found no influence of hormonal 
disorder on the operative time, while blood loss was 
higher for PH [10]. A diagnosis of pheochromocytoma 
has also been shown by other authors to be associated 
with increased blood loss. However, duration of surgery, 
when compared to LA for other indications, was also 
longer. This may be due to prominent vascularity, larger 
size and catecholamine output seen in these tumours [6, 
24, 25]. Karcher et al. reported that chromaffin tumours 
larger than 6 cm in diameter are associated with a longer 
operative time compared to other lesions. Blood loss, 
rate of intraoperative haemodynamic instability and 
hospital stay, however, was not associated with the size 
of these tumours [9].  
Our analysis showed that diagnosis of non-func-
tioning adrenal lesions and pheochromocytomas 
could have a significant influence on the length 
of time to ambulation of patients undergoing LA. 
Similar findings have also been reported by other 
authors [9, 10, 26–28]. Gotoh et al. reported a longer 
return to normal activity in patients undergoing LA 
for PH compared to other entities [24]. This was not 
confirmed in our series. 
In our study, we did not observe a significant 
influence of the type of tumour on the rate of in-
traoperative and postoperative complications. The 
commonest complication in our series, as in reports 
by others, was tissue bleeding [29]. In most cases 
this could be controlled surgically during LA, but in 
three cases conversion to open surgery was necessary 
because the ongoing tissue bleeding did not allow 
for safe tumour dissection. Lesion of the peritoneum 
occurred in five patients undergoing extraperitoneal 
LA. Diaphragmatic injury was observed in three 
patients and resulted in pneumothorax treated by 
thoracic drainage. In all cases it occurred during 
the right extraperitoneal procedure. We had also 
experienced two severe bleedings from the adrenal 
or inferior caval vein during removal of the right 
adrenal lesion. Some authors have observed a higher 
rate of intraoperative complications for patients oper-
ated on for PH [3, 10]. According to others, however, 
the number of complications related to endoscopic 
removal of PH depends first of all on the surgeon’s 
experience with advanced laparoscopic procedures, 
and is comparable to the outcome of LA performed 
for other hormonal disorders [9, 30]. 
In most cases, we had minor postoperative compli-
cations only. Neuralgia with temporary paresis of the 
right upper limb and acute adrenal insufficiency were 
the only severe postoperative disorders. The acute ad-
renal insufficiency that occurred after the removal of 
PH resulted in the death of one patient on the fourth 
postoperative day. This severe complication occurs 
in slightly more than 1% of patients and is specific 
for pheochromocytoma [29]. Other authors have also 
reported a similar complication rate regardless of the 
type of hormonal disorder associated with the adrenal 
tumour [4, 6, 10].
Conversion to OA ranges between 0 and 13% [10]. 
According to many authors, uncontrollable bleeding 
is the main indication for it [5, 31–33]. In our series, 
the cause and the rate of conversion to OA did not de-
pend on the underlying hormonal disorder. The most 
frequent indications to convert the procedure were 
difficult dissection or detection of the adrenal tumour, 
ongoing tissue bleeding, lesion of the peritoneum dur-
ing the extraperitoneal approach, pneumothorax as 
well as injury of the adrenal or inferior caval vein. The 
recent meta-analysis by Gumbs and Gagner indicated 
no significant difference regarding the conversion rate 
between all types of LA despite the hormonal activity 
of the removed tumours [10]. 
Similarly to the complication rate, the number of 
conversions may mostly depend on the experience of 
the surgeon rather than the type of hormonal disorder 
[8, 9, 15, 33, 34]. Shen et al, however, based on an analysis 
of 456 LAs, found that the size of the tumour, Body Mass 
Index and the diagnosis of PH are all predictive factors 
for conversion to OA [35].
In conclusion, this study shows that LA allows for 
a safe approach to benign adrenal lesions regardless 
of their different hormonal activity. The outcome of 
the procedure does not generally depend on the type 
of hormonal disorder diagnosed with the adrenal tu-
mour. Moreover, pheochromocytoma can be removed 
laparoscopically with the same safety and efficacy as 
other benign adrenal lesions. 
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